Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Anne M. Akkerman-Nijland, Onno W. Akkerman, Floris Grasmeijer, Paul Hagedoorn, Henderik. W. Frijlink, Bart. L. Rottier, Gerard. H. Koppelman & Daniel. J. Touw. (2021) The pharmacokinetics of antibiotics in cystic fibrosis. Expert Opinion on Drug Metabolism & Toxicology 17:1, pages 53-68.
Read now
Read now
Claire H. Masterson, Sean D. McCarthy, Daniel O’Toole & John G. Laffey. (2020) The role of cells and their products in respiratory drug delivery: the past, present, and future. Expert Opinion on Drug Delivery 17:12, pages 1689-1702.
Read now
Read now
Kholoud E Albinali, Moustafa M Zagho, Yonghui Deng & Ahmed A Elzatahry. (2019) A perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems. International Journal of Nanomedicine 14, pages 1707-1723.
Read now
Read now
Young Ae Kang & Won-Jung Koh. (2016) Antibiotic treatment for nontuberculous mycobacterial lung disease. Expert Review of Respiratory Medicine 10:5, pages 557-568.
Read now
Read now
Mark Elphick, Dirk von Hollen, John N Pritchard, Kurt Nikander, Lucy EA Hardaker & Ross HM Hatley. (2015) Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opinion on Drug Delivery 12:8, pages 1375-1387.
Read now
Read now
Martha K Daddario, Jennifer K Hagerman & Michael E Klepser. (2010) Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis. Infection and Drug Resistance 3, pages 123-132.
Read now
Read now
Rafael Zaragoza, Javier Pemán, Miguel Salavert, Ángel Viudes, Amparo Solé, Isidro Jarque, Emilio Monte, Eva Romá & Emilia Cantón. (2008) Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?. Therapeutics and Clinical Risk Management 4:6, pages 1261-1280.
Read now
Read now
Stanley B Fiel. (2008) Aerosolized antibiotics in cystic fibrosis: current and future trends. Expert Review of Respiratory Medicine 2:4, pages 479-487.
Read now
Read now
Yuanyuan Xie, Pengyun Zeng & Timothy S Wiedmann. (2008) Disease guided optimization of the respiratory delivery of microparticulate formulations. Expert Opinion on Drug Delivery 5:3, pages 269-289.
Read now
Read now
Jennifer K Hagerman, Stephanie A Knechtel & Michael E Klepser. (2007) Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature. Expert Opinion on Pharmacotherapy 8:4, pages 467-475.
Read now
Read now
Articles from other publishers (43)
Chih-Yung Chang, Bang-Hung Yang, Chien-Chih Ke, Jing-Long Hsu, Rong-Hong Jhou, Wen-Yi Chang, Nan-Jing Peng & Ren-Shyan Liu. (2022) Performance and Feasibility of Therapeutic Vibrating Mesh Nebulizer for Ventilation Lung Scan. Journal of Medical and Biological Engineering 42:6, pages 839-844.
Crossref
Crossref
Chad W. Stratilo, Scott Jager, Melissa Crichton & James D. Blanchard. (2020) Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax. PLOS ONE 15:1, pages e0228162.
Crossref
Crossref
Alexandra F. Freeman & Steven M. Holland. 2020. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
1113
1127
.
Subhabrata Ray, Sayani Bhattacharyya, Parthasarathi Panda, Awantika Pandey & Kajal Ghosal. 2020. Nano Medicine and Nano Safety. Nano Medicine and Nano Safety
237
266
.
Tim Rahmel, Alexandra Koniusch, Martin Schwertner, Günther Oprea, Michael Adamzik & Hartmuth Nowak. (2019) Evaluation of inhaled salbutamol effectiveness under supportive use of electrical impedance tomography in ventilated ICU patients: study protocol for a randomised controlled clinical trial. BMJ Open 9:3, pages e026038.
Crossref
Crossref
Nehal A. HassanFaten Farid AwdallahMaggie M. AbbassiNirmeen A. Sabry. (2018) Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial*. Critical Care Medicine 46:1, pages 45-52.
Crossref
Crossref
Kazuma Yagi, Makoto Ishii, Ho Namkoong, Takahiro Asami, Osamu Iketani, Takanori Asakura, Shoji Suzuki, Hiroaki Sugiura, Yoshitake Yamada, Tomoyasu Nishimura, Hiroshi Fujiwara, Yohei Funatsu, Yoshifumi Uwamino, Tetsuro Kamo, Sadatomo Tasaka, Tomoko Betsuyaku & Naoki Hasegawa. (2017) The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infectious Diseases 17:1.
Crossref
Crossref
Maizbha U. Ahmed, Tony Velkov, Yu-Wei Lin, Bo Yun, Cameron J. Nowell, Fanfan Zhou, Qi Tony Zhou, Kim Chan, Mohammad A. K. Azad & Jian Li. (2017) Potential Toxicity of Polymyxins in Human Lung Epithelial Cells. Antimicrobial Agents and Chemotherapy 61:6.
Crossref
Crossref
Kamal Hamed & Laurie Debonnett. (2017)
Tobramycin inhalation powder for the treatment of pulmonary
Pseudomonas aeruginosa
infection in patients with cystic fibrosis: a review based on clinical evidence
. Therapeutic Advances in Respiratory Disease 11:5, pages 193-209.
Crossref
Crossref
Jia‐Wei Yang, Li‐Chao Fan, Hai‐Wen Lu, Xia‐Yi Miao, Bei Mao & Jin‐Fu Xu. (2015) Efficacy and safety of long‐term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta‐analysis. The Clinical Respiratory Journal 10:6, pages 731-739.
Crossref
Crossref
Eric Wenzler, Dustin R. Fraidenburg, Tonya Scardina & Larry H. Danziger. (2016) Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clinical Microbiology Reviews 29:3, pages 581-632.
Crossref
Crossref
Nanci Yuan & Laura M. Sterni. 2016. Caring for the Ventilator Dependent Child. Caring for the Ventilator Dependent Child
145
164
.
Tony Velkov, Nusaibah Abdul Rahim, Qi (Tony) Zhou, Hak-Kim Chan & Jian Li. (2015) Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead. Advanced Drug Delivery Reviews 85, pages 65-82.
Crossref
Crossref
Dorota Sands, Ewa Sapiejka, Grzegorz Gąszczyk & Henryk Mazurek. (2014) Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS. Journal of Cystic Fibrosis 13:6, pages 653-660.
Crossref
Crossref
Aline Vidal Lacerda Gontijo, Nicolas Grégoire, Isabelle Lamarche, Patrice Gobin, William Couet & Sandrine Marchand. (2014) Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 2. Colistin. Antimicrobial Agents and Chemotherapy 58:7, pages 3950-3956.
Crossref
Crossref
Aline Vidal Lacerda Gontijo, Julien Brillault, Nicolas Grégoire, Isabelle Lamarche, Patrice Gobin, William Couet & Sandrine Marchand. (2014) Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 1. Ciprofloxacin, Moxifloxacin, and Grepafloxacin. Antimicrobial Agents and Chemotherapy 58:7, pages 3942-3949.
Crossref
Crossref
Alexandra F. Freeman & Steven M. Holland. 2014. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
919
929
.
R. Siekmeier, T. Hofmann & G. Scheuch. 2015. Inflammatory Disorders. Inflammatory Disorders
13
24
.
Robert Wilson, Sanjay Sethi, Antonio Anzueto & Marc Miravitlles. (2013) Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. Journal of Infection 67:6, pages 497-515.
Crossref
Crossref
Navin Kumar Verma, Kieran Crosbie-Staunton, Amro Satti, Shane Gallagher, Katie B Ryan, Timothy Doody, Colm McAtamney, Ronan MacLoughlin, Paul Galvin, Conor S Burke, Yuri Volkov & Yurii K Gun’ko. (2013) Magnetic core-shell nanoparticles for drug delivery by nebulization. Journal of Nanobiotechnology 11:1, pages 1.
Crossref
Crossref
Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink & Anne H. de Boer. (2012) Characterisation of high dose aerosols from dry powder inhalers. International Journal of Pharmaceutics 437:1-2, pages 242-249.
Crossref
Crossref
Tareq Abu-Salah & Rajiv Dhand. (2011) Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update. Advances in Therapy 28:9, pages 728-747.
Crossref
Crossref
K.D. Bruce, G.B. Rogers & N. Patel. (2011) Microbiological insights into respiratory infections and the opportunities for inhaled therapy. Journal of Drug Delivery Science and Technology 21:4, pages 301-309.
Crossref
Crossref
Félix Baranda, Ainhoa Gómez & Beatriz Gómez. (2011) Antibioterapia inhalada en otras enfermedades respiratorias. Archivos de Bronconeumología 47, pages 24-29.
Crossref
Crossref
Yu Zhang, Xiaoli Wang, Xia Lin, Xiaoliang Liu, Bin Tian & Xing Tang. (2010) High azithromycin loading powders for inhalation and their in vivo evaluation in rats. International Journal of Pharmaceutics 395:1-2, pages 205-214.
Crossref
Crossref
John DenyerIvan PrinceEmma DixonPenny AgentJennifer PryorMargaret Hodson. (2010) Evaluation of the Target Inhalation Mode (TIM) Breathing Maneuver in Simulated Nebulizer Therapy in Patients with Cystic Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23:s1, pages S-29-S-36.
Crossref
Crossref
A. Michalopoulos & E. Papadakis. (2010) Inhaled Anti-infective Agents: Emphasis on Colistin. Infection 38:2, pages 81-88.
Crossref
Crossref
Amparo SolÉ. 2010. Progress in Mycology. Progress in Mycology
95
140
.
Rafael Zaragoza, Javier Pemán, Miguel Salavert, Amparo Solé, Isidro Jarque, Emilio Monte, Eva Romá & Emilia Cantón. 2010. Combating Fungal Infections. Combating Fungal Infections
241
272
.
Alexandra F Freeman & Steven M Holland. (2009) Antimicrobial prophylaxis for primary immunodeficiencies. Current Opinion in Allergy & Clinical Immunology 9:6, pages 525-530.
Crossref
Crossref
Pavan Muttil, Chenchen Wang & Anthony J. Hickey. (2009) Inhaled Drug Delivery for Tuberculosis Therapy. Pharmaceutical Research 26:11, pages 2401-2416.
Crossref
Crossref
Miguel Ángel Martínez García, Luis Máiz Carro & Javier de Gracia Roldán. (2009) Tratamiento de las bronquiectasias en el adulto. Medicina Clínica 133:11, pages 433-440.
Crossref
Crossref
Dominique Hubert, Sylvie Leroy, Raphaële Nove-Josserand, Marlène Murris-Espin, Laurent Mely, Stéphane Dominique, Bertrand Delaisi, Pearl Kho & John M Kovarik. (2009) Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis. Journal of Cystic Fibrosis 8:5, pages 332-337.
Crossref
Crossref
Min Zhao, Yu You, Yachao Ren, Yu Zhang & Xing Tang. (2008) Formulation, characteristics and aerosolization performance of azithromycin DPI prepared by spray-drying. Powder Technology 187:3, pages 214-221.
Crossref
Crossref
Amparo Solé. (2008) Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B. International Journal of Antimicrobial Agents 32, pages S161-S165.
Crossref
Crossref
Amparo Solé & Miguel Salavert. (2008) Fungal infections after lung transplantation. Transplantation Reviews 22:2, pages 89-104.
Crossref
Crossref
Bruce K. Rubin. (2008) Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis. Journal of Aerosol Medicine and Pulmonary Drug Delivery 21:1, pages 71-76.
Crossref
Crossref
Bruce K. Rubin. (2008) Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis. Journal of Aerosol Medicine 0:0, pages 080208124710593-6.
Crossref
Crossref
Amanda Howard-Thompson & Michael L. Christensen. (2008) Elevated Tobramycin Concentrations Following Endotracheal Administration in a Premature Infant. The Journal of Pediatric Pharmacology and Therapeutics 13:2, pages 88-92.
Crossref
Crossref
Shin-Woo Kim, Joseph L. Kuti & David P. Nicolau. (2008) Inhaled antimicrobial therapies for respiratory infections. Current Infectious Disease Reports 10:1, pages 29-36.
Crossref
Crossref
Kala K Davis, Peter N Kao, Susan S Jacobs & Stephen J Ruoss. (2007) Aerosolized amikacin for treatment of pulmonary Mycobacterium aviuminfections: an observational case series. BMC Pulmonary Medicine 7:1.
Crossref
Crossref
Petra Dames, Bernhard Gleich, Andreas Flemmer, Kerstin Hajek, Nicole Seidl, Frank Wiekhorst, Dietmar Eberbeck, Iris Bittmann, Christian Bergemann, Thomas Weyh, Lutz Trahms, Joseph Rosenecker & Carsten Rudolph. (2007) Targeted delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology 2:8, pages 495-499.
Crossref
Crossref
David E. Geller, Michael W. Konstan, Jeffrey Smith, Sarah B. Noonberg & Carol Conrad. (2007) Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety. Pediatric Pulmonology 42:4, pages 307-313.
Crossref
Crossref